Elevated levels of preoperative CA 15-3 and CEA serum levels have independently poor prognostic significance in breast cancer (Q34646288)

3 August 2017

title

Elevated levels of preoperative CA 15-3 and CEA serum levels have independently poor prognostic significance in breast cancer (English)

1 reference

3 August 2017

J S Lee

1

1 reference

3 August 2017

S Park

2

1 reference

3 August 2017

J M Park

3

1 reference

3 August 2017

J H Cho

4

1 reference

3 August 2017

S I Kim

5

1 reference

3 August 2017

B-W Park

6

1 reference

3 August 2017

publication date

9 December 2012

1 reference

3 August 2017

1 reference

3 August 2017

volume

24

1 reference

3 August 2017

issue

5

1 reference

3 August 2017

page(s)

1225-1231

1 reference

3 August 2017

cites work

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS604

Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS604

Pathological prognostic factors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS604

Prospective evaluation of carcinoembryonic antigen (CEA) and carbohydrate antigen 15.3 (CA 15.3) in patients with primary locoregional breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS604

Prognostic role of CA15.3 in 7942 patients with operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS604

Long-term prognostic study of carcinoembryonic antigen (CEA) and carbohydrate antigen 15-3 (CA 15-3) in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS604

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS604

Tumour marker measurements in the diagnosis and monitoring of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS604

Postoperative follow-up of breast cancer patients: overview and progress in the use of tumor markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS604

Serum tumor markers in breast cancer: are they of clinical value?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS604

Preoperative CA 15-3 and CEA serum levels as predictor for breast cancer outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS604

Nation-wide Korean breast cancer data from 2008 using the breast cancer registration program

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS604

Relationship between CA 15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS604

Tumor markers in breast cancer- European Group on Tumor Markers recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS604

Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS604

Preoperative values of CA 15-3 and CEA as prognostic factors in breast cancer: a multivariate analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS604

Serum CEA and CA 15-3 as prognostic factors in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS604

High preoperative CA 15-3 concentrations predict adverse outcome in node-negative and node-positive breast cancer: study of 600 patients with histologically confirmed breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS604

"Tumour marker guided" salvage treatment prolongs survival of breast cancer patients: final report of a 7-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDS604

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDS604

1 reference

3 August 2017

1 reference